24 Nov 2014
Grace Zhang Receives NIH New Innovator Award
Medical researchers are steps closer to creating human organs using 3D printers, but they have significant barriers to cross before science fiction becomes a reality.
A George Washington University researcher is addressing those obstacles with a project that could pave the way for complex tissue regeneration.
Lijie Grace Zhang, an assistant professor in the School of Engineering and Applied Science, has received a prestigious 2014 Director’s New Innovator Award f...
22 Jan 2014
Rachid Yazami awarded the 2014 Charles Stark Draper Prize
Congratulations to our author, Rachid Yazami, in winning the 2014 Charles Stark Draper Prize! The National Academy of Engineering annually awards the Charles Stark Draper Prize, which is given for the advancement of engineering and the education of the public about engineering. It is one of three prizes that constitute the "Nobel Prizes of Engineering". Rachid Yazami is editor of Nanomaterials for Lithium-Ion Batteries. The following article was reproduced from N...
22 Jan 2014
Interview with Vladimir P Torchilin
Vladimir P Torchilin is a University Distinguished Professor and Director at the Center for Pharmaceutical Biotechnology and Nanomedicine at the School of Pharmacy, Northeastern University (MA, USA). He has published over 350 original research papers and among many other awards was the recent recipient of the 2012 Bangham Award, for his contributions to the study of liposomes. Professor Torchilin spoke to Therapeutic Delivery about the progress and challenges of the f...
20 Aug 2013
Medical Device Sharing with Regulators
Hong Kong, 12th June, 2013 – Local Responsible Persons (LRP) Panel Meeting for medical device regulators in Hong Kong.
Raymond K. Y. Tong (2nd from left) with the participants from the government and medical device companies. The LRP Panel meeting is a regular meeting and opens to all companies or individuals to provide free-of-charge and interactive platform to share the latest regional and global requirements in medical devices. Raymond Tong (Chairman of the LRP panel meeting a...
22 Feb 2013
Treatment Hope for Patients with Incurable Blood Cancer
A signature characteristic of Mantle Cell Lymphoma (MCL) is the excessive over-production of a cell growth protein due to an overactive gene. At Tel Aviv University in Israel, scientists have now developed a new class of drugs based on RNA interference that can destroy the malfunctioning proteins. This discovery brings the medical community one step closer to treating this form of incurable blood cancer.
A key feature of MCL, an incurable B cell non-Hodgkins lymphoma with an average lifespan...